BloodPressureHeartMeds.Net

Abbott to highlight latest research findings on HUMIRA at ACR annual meeting

October 25, 2017

Study Related to Long-Term Efficacy and Safety of Adalimumab for up to Six Years in Patients with Juvenile Idiopathic Arthritis; D. Lovell, et al

Abstract 265; Poster Session; November 6, 2011; 9 a.m. ?? 11 a.m.; Location: Poster Hall

Ankylosing Spondylitis/Spondyloarthritis

Five-Year Results Related to Improvement of Spinal Mobility, Physical Function and Quality of Life in Patients with Ankylosing Spondylitis; D. van der Heijde, et al

Abstract 535; Poster Session; November 6, 2011; 9 a.m. ?? 11 a.m.; Location: Poster Hall

Results from a Phase 3 Study Related to Efficacy and Safety of Adalimumab in Patients with Non-Radiographic Axial Spondyloarthritis; J. Sieper, et al

Abstract 2486A; Oral Abstract Session; November 8, 2011; 2:30 p.m.; Location: W 475 A

Health and Economic Outcomes

Study Related to The Impact of Disease Duration on Work Status in Patients with Rheumatoid Arthritis; L. Harrold, et al

Abstract 108; Poster Session; November 6, 2011; 9 a.m. ?? 11 a.m.; Location: Poster Hall

Impact of Juvenile Idiopathic Arthritis on Parents' Work Absences; R. Rasu, et al

Abstract 259; Poster Session; November 6, 2011; 9 a.m. ?? 11 a.m.; Location: Poster Hall

Work Absences and Costs Associated with Rheumatoid Arthritis: A Comparison between Employees with and without Rheumatoid Arthritis in a U.S. Population; R. Brook, et al

Abstract 913; Poster Session; November 7, 2011; 9 a.m. ?? 11 a.m.; Location: Poster Hall

Study Related to Effect of Adalimumab on Function, Health-Related Quality of Life, Work Productivity and Daily Activities in Patients with Non-Radiographic Axial Spondyloarthritis; W. Maksymowych, et al

Abstract 1312; Poster Session; November 7, 2011; 9 a.m. ?? 11 a.m.; Location: Poster Hall

Validation of the Patient Acceptable Work State: Establishing Thresholds for Patient-Reported Outcomes in a Longitudinal, Observational Study in Patients with Ankylosing Spondylitis; W. Maksymowych, et al

Abstract 1326; Poster Session; November 7, 2011; 9 a.m. ?? 11 a.m.; Location: Poster Hall

Results from a 26-Week Analysis of Combination Therapy with Adalimumab+Methotrexate Related to Work Ability, Physical Function, Fatigue and Other Patient-Reported Outcomes in Early Rheumatoid Arthritis; R. van Vollenhoven, et al

Abstract 2189; Poster Session: November 8, 2011; 9 a.m. ?? 11 a.m.; Location: Poster Hall

SOURCE Abbott